Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 4
1(20.0%)
5Total
N/A(4)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04228627Phase 4Completed

Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial

Role: collaborator

NCT07316959Not ApplicableCompleted

Efficacy of Long-Term Low Dose Macrolide Therapy in Preventing Early Recurrence of Nasal Polyps After Endoscopic Sinus Surgery

Role: lead

NCT06142981Not ApplicableCompleted

PRP and PBD-VSEL Stem Cell Therapy for Parkinson's Disease

Role: lead

NCT06999135Not ApplicableCompleted

Comparison of Silodosin and Tamsulosin for Medical Expulsive Therapy in Patients With Ureteral Stones

Role: lead

NCT06173856Not ApplicableCompleted

Effectiveness of Phototherapy With and Without Probiotics

Role: lead

All 5 trials loaded